biote Corp.
Close on Oct 19, 2026
- Market cap
- $30.92M
- P/E (TTM)
- 10.8
- Dividend yield
- –
About biote
Medicinal Chemicals & Botanical Products, SIC 2833
biote Corp. operates in the wellness and healthcare sector, developing and providing the Biote Method along with Biote-branded dietary supplements and convenience kits. The company provides training programs and methodology for medical clinics and practitioners, allowing prescribers to offer compounded bioidentical hormone pellets, supplements, and related procedures to their patients. In addition to delivering clinical training services and contract term services, the business supports the sale and distribution of dietary supplements, disposable trocars, and procedure-related supplies directly to partnered clinics and certified healthcare professionals.
The company conducts its business primarily within the United States while also engaging in sales across Mexico and other foreign locations. Its commercial operations rely on a network of Biote-partnered clinics and Biote-certified practitioners concentrated in particular geographic regions. biote Corp. is incorporated in the state of Delaware, maintaining its principal executive offices and corporate headquarters in Irving, Texas.
Summary of the business section of biote's latest annual report, written by StockData.
Company profile
Company
- Legal name
- biote Corp.
- Headquarters
- Irving, TX
- Address
- 1875 W. Walnut Hill Ln #100 75038
- Phone
- (972) 486-9346
- Employees
- 223, Dec 31, 2025
- Industry
- Medicinal Chemicals & Botanical Products
- Fiscal year ends
- December 31
- Auditor
- Deloitte & Touche LLP, Dallas, Texas
Stock & identifiers
- Ticker
- BTMD
- Exchange
- Nasdaq
- IPO date
- Mar 3, 2021
- Shares outstanding
- 36M, Aug 5, 2026
- Public float
- $97.90M, Jun 30, 2025
- Filer category
- Accelerated filer<br>Smaller reporting company<br>Emerging growth company
- SEC CIK
- 1819253
- CUSIP
- 090683103
- ISIN
- US0906831039
- EIN
- 85-1791125
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Marc D. Beer | Executive Chairman, Director | 3,206,836 |
| Robert Charles Peterson | Interim CEO, Director | 0 |
| Daniel Michael Monico | General Counsel | 1 |
| Mary Elizabeth Conlon | General Counsel | 140,393 |
| Bret Christensen | Director | 37,595 |
| Andrew R. Heyer | Director | 2,292,156 |
| Dana Lynn Jacoby | Director | 63,964 |
| Stephen Mark Cone | Director | 160,829 |
| Debra L. Morris | Director | 71,562 |
| Richard R. Barrera | Director | 4,622,748 |
| Steven J. Heyer | Director | 729,856 |
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had 223 employees, across 11 departments.”
Corporate history
Events identified from SEC filings